University of Cambridge > Talks.cam > Euroscicon > Strategies for commercial success of biosimilars in an increasingly crowded market place

  Browse A-Z

Log in

University Account External (via Google)

🔐 Log In

Information on

Subscribing to talksdetails Finding a talkdetails Adding a talkdetails Disseminating talksdetails Help and Documentationdetails

ℹī¸ Information

Strategies for commercial success of biosimilars in an increasingly crowded market place

Download to your calendar using vCal

If you have a question about this talk, please contact Dr Shara Cohen .

http://www.regonline.co.uk/biosimilars2012

Whilst biopharmaceuticals remain a major component of the global therapeutics market, the ever expanding portfolio of products losing patent protection and with increasing healthcare costs remaining a poignant issue, the opportunity for development of competing, follow on biologics remains an attractive proposition for both Biotech and Pharma companies alike. This Euroscicon biosimilars conference will focus on multiple aspects of biosimilar product development to successfully deliver safe, biosimilar products to the market place.

This talk is part of the Euroscicon series.

This talk is included in these lists:

Note that ex-directory lists are not shown.

Other lists

Webinar & LT2, Computer Laboratory, William Gates Building. Hybrid: in-person in Cambridge & online via Teams Max Perutz Lecture Theatre. LMB. Cambridge.

Other talks

Afternoon Break Title to be confirmed: CMS Seminars in Cancer Geometry and Generalization: The case of Grokking On convective penetration of a buoyant plume into a stably stratified layer TBC
 

Š 2006-2025 Talks.cam, University of Cambridge. Contact Us | Help and Documentation | Privacy and Publicity